• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The invention relates to a process for the preparation of peptides which consist of from 6 to 20 amino acid residues, in particular v pancreozyme peptides, for the biological activity of which a tyrosine residue must be esterified with sulfuric acid, and to their pharmaceutically acceptable salts. The invention is based on the object, Boc-Tyr (SO ^). Met-Gly-Trp-Met-Asp-PheNHp with high yields while avoiding expensive purification operations of the commercial product Trp-Met-Asp-PheNK to win. According to the invention, a protected tyrosine peptide from 2 to 6 amino acid esters curci Eimvirkung of an excess of pyridine-SO ^ complex or of
    公开号:SU920053A1
    申请号:SU777770038
    申请日:1977-12-12
    公开日:1982-04-15
    发明作者:Хартмут Нидрих；Бригитте Хертель；Михаель Бинерт；Манфред Кейлерт
    申请人:Академие Дер Виссеншафтен Дер (Инопредприятие)；
    IPC主号:
    专利说明:

    the introduction of a saturated dipeptide with {- / - decapes. containing tyrosine sulfate. Sulfuric acid D tyrosine residue is introduced into the unprotected octapeptide by means of concentrated sulfuric acid, and due to the formation of a large amount of by-products, the yield after purification is 20% to -25. In the same way, a number of PZ-octapeptide analogs are obtained, of which N-terminal aspartic acid from other amino acid residues, maleic and furmaric acid / raMi-iJ, are also biologically highly active,
    The sulfonated on the aromatic ring of tyrosine in the position ЗР2-Octa, Deca-20 and dodecapeptides, obtained by using centered saric acid, show high biological activity. Others (by-products in the preparation of C-terminal PZ sequences are starting materials, i.e. an identical non-sulphated series, which can also be entrusted by cleavage during processing due to a short-term acidic reaction, .. derivatives with tryptophan ring substitutions, which can be formed during stepwise synthesis with repeated cleavage of protective groups of Boc by means of trifluoroacetic acid. The simplest-PZ-nen type of high biological activity obtained in the synthesis process is Boc-Tyr ( SO j-} Met-Gl3 / -rp-Met-Asp-PheNlIj Sulfuric acid residue is introduced into Bose-heptapeptide at the last stage. For most active peptide substances, the removal of the N-terminal amino group enhances the biological activity, and that the introduction of N-terminal The acyl groups are furthermore prevented from cleavage by aminopeptidases, which is advantageous for biological activity. The aim of the invention is to obtain the shortest path through Bos-Tug (50G) -№t-Gly-Tip-r .fet-Asi:) - P ieMi2 with a high yield percentage, avoiding an uneconomical cleaning operation, based on industrial prod KTA Trp-Met Asp-PIieMi use as a starting material for the preparation follows blowing, especially N-acyl-PE peptides and, starting from this, the floor
    PZ-peptide acting on the gallbladder according to the possibility with a simple structure.
    The goal is achieved by
    that esterified with sulfuric acid on tyrosine A protected peptide containing 2-6 amino acid residues is used as an intermediate product.
    The method of obtaining X-TyrfSOjJ-Met-Gly-Tn-Met-AsD-PhcMl, where -.X HsO OOC-CHi-CH., -CO; HO-Cg, CO; HOOC - CH ,, Qig.CO, and other acyl residues are that
    The Y-Tyr MetGly-0-alkyl whelped tripeptide ester is sulfonated, the ester group is cleaved off by saponification, the protected sulfated tripeptide is condensed with Tr {: i rvfet-Asp-PheMl2, mainly by the mixed anhydride method, and obtained after cleavage of the protective group, heptapto-Asp-PheMl2, mainly by the method of mixed anhydrides, and obtained after cleaving the protective group. acylated. with the addition of a weak organic alkali, mainly Nethylmorpholine. In the processing of the product after sulfonation, water-alkaline buffer solution is used, mainly. To isolate a protective tripeptide, mixtures of higher alcohols with ethyl acetate, preferably n-butanol / ethyl acetate, are used. Tertiary butyloxycarbonyl is used as a protecting group, and its cleavage from heptapeptide is carried out with trifluoroacetic acid, when methoxybenzenemercaptoethanol is added in excess at room temperature. The fractions of the desulfated peptide of the same amino acid sequence obtained by acid treatment are separated after the acylation of the amine group. There is a method used for the synthesis of higher tyrosine sulphate peptides using the example of several N-acy-. of lylated C-terminal heptapeptides pancreaticimine (PZ}. X-Tyr (OS05) -Met-Gly-Trp-Met-Asp-PheNH where: X HOOG-aLCH CO; HG - CH OGO-GH.r-GLg-CO -, Y-BUT-CaHz-CH CO. In the proposed method, a protected peptide fragment, which can
    5 9200536
    consist of 2-6 residues of amino acid formation of fasting by-products and contain a tyrosine residue, are esterified by exposure to an excess of the pyridine-SOj complex or
    a mixture of pyridine, chlorosulfuric acid 5dl butyloxycarbonyl cleavage
    In dimethylformamide / chloroform and a sulfur-protecting group, the acid is used. By sulphating trifluoroacetic acid Boc-Tyr-Met-Gly-OAt with a 30-fold excess in the presence of an бы-excess of Cl-SOjH mercapto in the mixture, 100% ethanol and methoxybenzene are reached. Wherein
    transform. Separation of the ester-Jupol bond eliminates adverse reaxeric acid due to the short-term acidic reaction when processing the reaction mixture is prevented from being placed in an alkaline buffer system. for example NHj / Mli, Cl. The reaction product 15 can be easily extracted from a buffer mixture of a mixture of higher alcohols, for example, l-butanol or acetic acid ester with a yield of 70. The advantage of this method is that O-acyltyrosine contaminated derivatives of protected tyrosine, for example NO, can also be used. -Di-Boc-Tyr which is very expensive to clean. Upon treatment with the release, the resulting 0-acyl-tyrosine peptide is quantitatively removed from the tyrosine sulfate peptide. Bose-Tug (SOp-Met-Gly-OXt is converted by alkaline saponification in a known manner to tripeptide acid and liberated by n-butanol / ethyl acetate (75% yield). N-protected peptide acid containing tyrosine sulfate can be condensed using a conventional method. into the peptide with a free α-amino group. For the binding of Bos-Tug (S0) -Mst Gly to Trr-Me1-L5r-PehM12., the synthesis of mixed anhydrides is predominantly used (88% yield). Preparation of Boc-protected C-terminal pancreatocephalpephase peptide Bosh The (50) -MetGly-Trp-Met-Asp-PheNo-Ih-Ih occurs in this way with higher overall yield and higher frequency than by known synthesis methods in which sulphation is undertaken as the last stage of the reaction. Due to the proposed method, both are fully disintegrated by the nitrogen protecting group while simultaneously acidifying the ether-sulfuric acid bond, i.e. at the minimum cleavage of residue 80 from the hydroxy acid group of tyrosine, as well as the simultaneous minimum
    cyclic pinching at the tryptophan residue ..
    As a favorable condition
    on tryptophan. The hydrolysis of sulfuric acid ester remains below 20. It is very advantageous to use a butyloxycarbonyl protecting group as compared to the known protecting groups, which can be cleaved off in weakly acidic, neutral or alkaline media. The resulting peptide with a free hydroxyl group on the thirazole, which is identical in sequence, is very easily separated by subsequent nitrogen acylation, if this is necessary for the intended purpose of use. Acylation of the C-terminal pancreato-heptapeptide 1) obtained in this way 1) 1 (050) -Met-Gly-Trp Met-Asp-PheNIi; j. is carried out by reaction with the activated esters of the corresponding carboxylic acids, for example, with 2, 5-trichlorophenyl-P-hydroxyphenyl-acetic ester and ethyl succinic ester or with succinic anhydride. For this, hepa peptide is freed from trifluoroacetate by weak organic cleavage, mainly M-ethylmorfo, ,,. linine (. The acylation is carried out with the addition of N / Vt, the ion reprocessing remains on sulphonated heptapeptides. From the acyl-PZ-heptapeptididosuccinyl-PZ-hepta-peptide thus obtained, also referred to as desamino-p7-octapeptide, X-optane peptides, denoted by desamino-p7-octapeptide) -CO2) shows a high activity when exposed to the gallbladder, which is almost equivalent to the activity of cerulein. Derivatives of P-hydroxyphenylacetyl and ethoxy sulfonyl reach only 1% of the activity of iGuleulein. The separation of desulfated. Byproducts can be countercurrent Separation by chromatography on dextran gel - Since the molecular weight of both compounds differs drastically, the separation effect is striking. EXAMPLE 1 Ammonium salt of H-tert6u.poxycarbynol o-sulfate-tyrosmyl-L-methionyl-glycine- ethyl ester. 2j8 g of 0.03b mol) pyridine in 10 ml of chloroform is cooled to -10 ° C. While stirring the min, 2.1 ml of 0.037 mol) of chlorosulfuric acid is added dropwise to the solution and the temperature must be maintained at 4-1 . After the addition is complete, the reaction mass is stirred for another 30 minutes at C, and then a mixture of pyridine-80z complex and pyridine hydrochloride is added to 10 ml of dilatylformamide. 0.600 g (1.21 mol) of Boc-Tyr-tet-Gly-OAt, dissolved in 10 ml of dimethylformamide and 10 ml of pyridine and added with stirring to a solution of the pyridine 30z complex. Then, the mixture is stirred for 5 hours, heated in a water bath at +35 ° C, the solvent is removed in vacuo using an oil pump prim, and oil) - (the pure residue at (-5) 0 ° C with vigorous stirring is mixed very rapidly with 200 ml of 0.1 N-NH ,, C1 / / 0.1 N-MIj buffer solution (pH 10.5 Then the pH value of this buffer solution was quickly adjusted to 7.0. The solid precipitated from the aqueous phase was dissolved in by adding 70 ml of a mixture of n-butanol / ethyl acetate (2: 1). The aqueous phase is separated, saturated with NaCl and extracted three times with 70 ml of this mixture. Organic extractions The cells are combined, washed with a saturated solution of NaCl until the SOjj ion disappears and the organic phase is dried over. The solution is evaporated in half. The solution containing n-butanol of the Boc-TugGVos -Met-Gly-OAt separates slowly with stirring , 5 times the amount of cold ether. The precipitated product is filtered off with suction, washed thoroughly with ether and petroleum ether and dried in vacuo over .i. Yield: 0.50 g (). M.p. 139-1 1 ° С Wyr (-9.8) (C-1.0 in dimethylformamide). Amino acid analysis after alkaline hydrolysis: TorgO3 0.87; 0.05; Met 0.89; Gly 1.0. The purity of the product is checked by thin-layer chromatography on Cavaler Czecovaler syphol plates in the system (A) VION (ice on acetic acid / water (4: 1: 1) and (B) pyridine / and butanol / ice on acetic acid / water (20 : 30: 6: 24). 0.66; 0 ,, Example 2. Sodium salt of V-tert-butyloxycarboyl-O-sulfate and tyrosyl-b-methionyl-glycine. 0.5 pO g (0.84 mol) Vos-Tug (SO , Mi |) -Met-Gly-OAt is dissolved in 5 ml of a mixture of water and ethanol in a ratio of 1: 1 and at room temperature, f5 min is stirred with 3 ml of 1N NaOH. The solution is evaporated in a rotary c-vaporizer at + 40 ° C up to half of its volume and then break Add 5 ml of water. Set with 1N HCl at a pH of 3.0. The aqueous phase is extracted with 50 ml of n-butanol / ethyl acetate (2: 1), then saturated with NaCl and thoroughly shaken with two portions of the indicated solvent mixture. to 50 ml each. The organic phases are combined, washed with a saturated solution of NaCl and dried over Naj, SOi. The solvent is removed in vacuum at + kO ° C, the residue is dried many times with IM by evaporation with addition of chloroform. The glassy residue is plant - - - - dyed with ether - petroleum ether, the solid is thoroughly washed with ether and petroleum ether and dried in vacuum over PF0 | 0- Yield; 0.360 g (75); m.p. ige-igS c. k, p 6.8 (C-0.5 in dimethylformamide), d 0.64; R 0.57. Example 3 - Sodium salt of N-tertbutyloxycarbonyl-O-sulfate-L-tyrosyl-L-methionyl-glycine-b-tryptophyl-b-methionyl-b-aspartyl-b-phenylalanimimide. 0.360 g (0.631 mole) of Boc-Tug (SO 3 Na) -Met Gly-OH is dissolved in 20 ml of dimethylformamide, 0.079 ml (0.631 mole) of N-ethylformin is added and the reaction solution is cooled to -25 ° C. 0.086 ml (0.631 mol) of isobutyl chloroformate are added to it and then incubated for activation for 10 minutes at -25 ° C. 0.00 g (0.631 mol) of Trp-Met-Asp PheN i2, separate separately in 20 ml of dimethylformamide, mixed with 0.079 ml (0.631 mol) of N-ethylmorpholine and the reaction solution is cooled to. The resulting mixture is added to the Bosh-Tug SOjNai-Met-Gly-OH mixed anhydride solution. The mixture is then stirred for 30 minutes at and 4 hours at room temperature. The precipitated amine hydrochloride is filtered off with suction, the solvent is removed in vacuo using an oil pump, and the residue is triturated in the cold with an n-butanol – ether mixture (1: 1). The solid is sucked off, washed thoroughly with chloroform and dried in vacuum over P /, 0.5 ,. yield: 0.650 g (881). - mp. iS t186 ° C. tcClp G-7.1) (, 25 in dimethylformamide) 14Lo 3.7 (, 25 v) Amino acid analysis after alkaline hydrolysis: TyrSOA, 0.88; Tug 0.0 Phe 0.9; Asp 1.0. Rf 0.64; Rp 0.67. Example k. O-sulphate-b-thyrozyl-b-methionyl-glycine-b-tryptophyl-b-methionyl-b-aspartyl-b-phenylalan-amide-trifluoroacetate. 0.650 g (56 moles) Bos-Tug (SaNa vfet-Gly-Trp-f.fet-Asii-PheNH j is mixed with 0.5 ml of methoxybenzene and 0.1 ml of 1-mercaptoethanol and then mixed with 125 ml of acetic trifle for 20 minutes acid at 18–20 ° C. The reaction solution is added to two times the mixture of ether and petroleum ether (1: 1) and filtered off with loose sediment. Thoroughly washed with petroleum ether and dried in a vacuum over RCO, o / KOH. : 0.550 (85). Rf. 0.32 and 0.62 (about 20 °); Sch 0.57 and 0.77 (about 20 °); Amino acid analysis after alkaline hydrolysis: (305Н) 0.68; Tug 0; 23; Asp 0.74; Gly 1.0; Met 1.6; Phe 0.9; Trp 1.1. Example 5. N-succinoyl-O-sulfate 1, -t irozil-L-methionyl-glycine-L-trip TOFIL-L-meth ion and L-La cna ptil-L-phenylalaninamide 0.550 g (0, mol) of the product obtained in example k, is dissolved in 10 ml of dimethylformamide, with stirring mixed with 181 ml (0,-mole) of N-ethylmorpholine (no other base is to be used) and the reaction solution is cooled down until then 0.062 g of 0.00062 1 .mol) of succinic anhydride are added during tO min and 0.079 ml of N-ethylmorpholine is added dropwise. The reaction solution is stirred for an additional 3 hours and left to stand at + C ° C. The solvent is removed in vacuo on an oil pump at + kOC., And the viscous residue is triturated with a cold n-butanol-ether mixture, the solid is sucked off, washed thoroughly with carbon tetrachloride, ether and petroleum ether and dried in vacuo over Pj, Os. Yield: 0.588 g (91%). Mp 172-175 ° C. Amino acid analysis after alkaline hydrolysis: TugSoz 0.72, Here 0.18; Asp 1.0; Gly 1.1; Met 1.6; Phe 0.93; Tr-0.75; Rf. 0.53 and 0.70 (); Lp .. 064; and 0.68. (- 20%). Purification by gel filtration on Sephadex G-25. Sephadex G-25 swollen for several hours in a 0.1N solution of ammonium acetate (adding ammonia to 1N acetic acid to pH 6.5) is introduced into a 120 cm long column and a diameter of k cm. The solution is loaded with 200 mg of crude crude deaminoctapeptide in 8 ml Oh, 1 n. ammonium acetate solution and 2 ml of dimethylformamide and elute with 0.1 n. ammonium acetate solution. At a flow rate of 15 ml / h, the concentration of the peptide was determined by measuring the extinction at 280 um (Uvicord), the eluate was collected in 8 ml fractions. The fractions contain desamine-PZ-octapeptides, fractions 323 - desulfated by-product. Output 0.116 g (60) and 0.055 g () of desulfated heptapeptide M 3, ± 0, 0.25 in water tcL 9, A ± 0.25 in dimethylformamide Amino acid analysis after alkaline hydrolysis (Tyr (OSOn Here Asp Gly Met Phe Trp 0 , 80 0.08 1.0 1.0 1.64 0.90 1.8 Example 6. N-ethoxy succinyl-0-sulfate-L-tyrosyl-b-methionyl-glycine-b-tryptophyl-b-methionyl-b -aspar- .tyl-bphenylalanine-amide. 0.190 g (0.167; mol) Tyr (6sOj) - fet-Gly-Trp-fet-Asp-Phe Wr (example) was dissolved in 10 ml of dimethylformamide and added 0,0182 ml (O, Y6 -1 mol) N-ethylmorpholine. The reaction mixture is cooled to OC and
    lsbaol 0.059 g (0.182; -Mol} ether 2., 5 trichlorfeiyl-ethoxy-succinic acid, / | from: 1, Acetoid lasts 30 minutes at 0 and ostaz, poured for 2 days at room, ur. Solvent is removed under vacuum at an oily residue dilherirovat ether / petroleum ether, the solid is sucked off and rinse chloroform, ether and petroleum ether. Yield: 0, g, (751); Rfp, - 0.61 12 in; Rf 0.705 with desulfated , acylated heptapeptide,
    Purification by countercurrent separation
    Chloroform / methanol / o, 1 N, ammonium acetate (11.1: 8: 10) is used as the separation system. After 32 separation steps and lyophilization, the product yield is 8-t% (fractions 24-31), along with 153 desulfurized, acylated heptapeptide (fractions 20-22} - Acid-base titration and sulfate determination (VAZO) give 90% or computational values.
    Example 7-p-hydroxyphenylacetyl 0-sulfate-b-tyrosyl-b-methionyl-b-tryptophyl-b-methylnyl-b-aspartyl-L-phenylalaninamide.
    0.190 g (0.167 mol) of heptapeptide sulphate (as in the example) was dissolved in 10 ml of dimethylformamide, 0.0182 ml of 0.1) 6, mol) M - ethylmorpholine was added and the reaction mixture was cooled to. 5b mg (0.182 1 mol) of 2, (, 5-trichlorophenyl-p-hydroxyphenylacetic acid) ester is added, the mixture is stirred for 30 minutes at 0 ° C and at room temperature for two days. The solvent is removed in vacuo at + 45 ° C and the oily the residue is digested with ether / petroleum ether (1: 1). The solid is sucked off and washed with chloroform, ether with petroleum ether. Yield: 0.150 g (80); Rpb 0.59 with R 0.69 - desulfurized, acylated heptapeptide. countercurrent / separation. Yield (fractions 24-31) along with 15 desulfurized heptapeptide (fractions 11-23). Ki slot-base titration and sulfate determination (BaSO) give 95% or 93 calculated values: „
    Bos-tug-met-bw-oat
    0, pyridin-ZOg complex
    Boc-Tur-CSOj-Nl-Ll-Mjt-GPyOAtffS 5,, t4DH
    (SD3-Na) -Met- & 2y-OH (2) - Trp-Met- .5р-PheMHj 80
    Gynthesis of mixed anhydrides
    bDC TyrCSOsN5) -MEt -SC-Thr-Me-Scip-PheWH (5) -in5%
    . 51 TFE / Cg HsOPHj / HSA.T Tyr (S03) M8t-G y-Tpp - Met-Xsp-PHeNHsL TFE
    (W).-CO,
    With Igzo
    Q07osesradex.
    tli% Metr-fiBi / -Trp -Asp -PheMHa (5)
    Ho6c-DH - eHj -co-Tyr (so;) - Met-Gey
    -Met- / sp -PheWHi 75% -CO-HHi-CO-D-CfiHj.Cei H5CtO-CO-CH2.-CHa CO-Tyr (SDg) -Het C Trp-Met AspPheNH a (6)
    so% -HO-CsHM-CHa-CO-O-CbHaCtib HO-Cs -Nch-SNg-CO-T4g (50z) -Me1- & Thrp-Met-sp-pheMH2 «(1.
    invention formula
    1, Method for producing peptides containing tyrosine sulfate 6-20 amino acid residues with esterified sulfuric acid tyrosine, by sulfonating a protected peptide residue containing tyrosine, condensing it
    the usual methods of peptide chemistry with the amino group of another peptide containing 2-14 amino acid residues and subsequent substitution on the .J-amino group after cleavage of the protective group, characterized in that the N-protected peptide containing 2-6 amino acid residues esterified with sulfuric acid as an intermediate product.
    2, Method for producing X-T7g (50) -Met-Gly-Trp-Met-Asp-Phe // H, where:
    X% o oos-cng-cng-co, HO-CgHgai -cq
    HOOC-HCp-QIc-CO and other acyl
    . s.j
    residues according to claim 1, characterized in that the Y-TyT-Met-Gly-0-alkyl protected tripeptide ester is sulfonated, the ester group is cleaved off by saponification, the protected sulfonated tripeptide is condensed from Trp-Met-Asp-PheMlg mainly by the mixed anhydride method, and the heptapeptide obtained after cleavage of the protective group is acylated by the addition of a weak organic alkali, mainly M-ethylmorpholina.
    one
    3. The method according to paragraphs. 1 and 2, about 1 tl. And Washable by the fact that during the processing of the product after sulphonation, an aqueous alkaline buffer solution, mainly NH5 / NH (, C1, is used.
    k. A method according to claim 2, wherein the mixture is used to isolate the protective sulfonated tripeptide using mixtures of higher alcohols with
    with ethyl acetate, preferably H-butanol / ethyl acetate.
    5. Method - according to Claim 2, which means that TpetH4HbiH butyloxycarbonyl is used as the shield group and its cleavage by JOT of sulfonated heptapeptide is carried out with 75-85% trifluoroacetic acid by adding and excess methoxybenzenemercaptoethanol at room temperature .
    6. The method according to PP.1, 2 and 5 of that. It is obtained by the fact that the fractions of the desulphated peptide obtained from the acid treatment of the same amino acid sequence. separated after acylation of the amino group.
    权利要求:
    Claims (6)
    [1]
    Claim
    1. Method. Obtaining peptides, content. living tyrosine sulfate of 6-20 amino acid residues with tyrosine esterified with sulfuric acid, by sulfonation of the protected peptide residue containing tyrosine, condensation of it _, 0 by conventional peptide chemistry methods with the amino group of another peptide containing 2-14 amino acid residues, and subsequent substitution no Д, -amino group after cleavage of the protective group, characterized in that the N-protected peptide esterified with sulfuric acid at tyrosine containing 2-6 amino acid residues is used as 50 intermediate kta.
    [2]
    2. The method of obtaining X-Tyr (SO ^) - Met-Gly-Trp-Met-Asp-Pheift-l e , where:
    X = Н ^. О g ООС-СН £ -СНг-СО-, IIO-C 6 HgC1I r СО „НООС-НС g- СН 5 -С0 and other acyl 55 residues according to claim 1, characterized in that the protected tripeptide Y-Tyr-Met-Gly-O-alkyl ether is sulfonated, the alkyl ester group from 13 920С is ground by saponification, the protected sulfonated tripeptide is condensed with Trp-Met-Asp-PheNHg mainly by the mixed anhydrides method, and the heptapeptide obtained after cleavage of the protective '5 group is acylated by addition weak organic alkali, mainly N-ethylmorpholine.
    [3]
    3. The method according to PP. 1 and 2, which is characterized in that when processing the product after processing 10 after sulfonation, an aqueous alkaline buffer solution, mainly NH 3 / NHj, Cl, is used.
    [4]
    4. The method according to claim 2, characterized in that in order to isolate the sulfonated protective tripeptide, mixtures of higher alcohols with
    53 14-acetic acid, ether, mainly / n-butanol-ethyl acetate.
    [5]
    5 · The method according to claim 2, revealing that tertiary 'butyloxycarbonyl is used as a shield group and its cleavage of sulfonated heptapeptide is carried out with 75-85% trifluoroacetic acid with the addition and excess of methoxybenzene mercaptoethanol at room temperature.
    [6]
    6. The method according to PP.1, 2 and 5, about t lH and chisy that the obtained by acid treatment of the fraction de sulfated peptide of the same amino acid sequence. separated after acylation of the amino group.
    类似技术:
    公开号 | 公开日 | 专利标题
    Yang et al.1976|. beta.-Phenacyl ester as a temporary protecting group to minimize cyclic imide formation during subsequent treatment of aspartyl peptides with hydrofluoric acid
    KR950013679B1|1995-11-13|Symthetic resin
    US6255285B1|2001-07-03|Phenethylamine derivatives
    EP0009010B1|1983-03-02|Bradykinin inhibiting tripeptide derivatives, process for their preparation and pharmaceutical preparations containing them
    US4368192A|1983-01-11|Peptides
    FI77873B|1989-01-31|FOERFARANDE FOER FRAMSTAELLNING AV NYA, TERAPEUTISKT ANVAENDBARA POLYPEPTIDER.
    SU920053A1|1982-04-15|Method of producing peptides containing tyrosine sulphate
    US6235876B1|2001-05-22|Liquid phase process for the preparation of GNRH peptides
    DK151968B|1988-01-18|METHOD FOR PREPARING PENTAPEPTID H-ARG-X-ASP-Y-TIRE-R BY SOLUTION SYNTHESIS
    US3705140A|1972-12-05|Peptides related to the c-terminal sequence of cck-pz and caerulein
    US20060014929A9|2006-01-19|Liquid phase peptide synthesis of KL-4 pulmonary surfactant
    CS235072B2|1985-04-16|Method of l-tyrosyl-d-alanyl-glycyl-l-phenylalanylamide's new derivatives production
    US3388113A|1968-06-11|Protection of the guanidino group of arginine during peptide synthesis by the p-nitrocarbobenzoxy group
    EP0171315A1|1986-02-12|Process for the synthesis of hGRF | in the liquid phase, and intermediary peptides
    US4290943A|1981-09-22|Method of preparing polypeptides
    Lansbury Jr et al.1989|A practical method for the preparation of protected peptide fragments using the Kaiser oxime resin
    FR2557114A1|1985-06-28|NOVEL DERIVATIVES OF GONADOLIBERIN, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
    EP0132919B1|1986-10-29|Peptides
    Perich1991|[18] Synthesis of O-phosphoserine-and O-phosphothreonine-containing peptides
    SU1531857A3|1989-12-23|Method of obtaining peptides
    EP0161468A2|1985-11-21|Process for the solid phase synthesis of peptides which contain sulfated tyrosine
    RU2010799C1|1994-04-15|Derivatives of pentapeptides
    US4444682A|1984-04-24|Method of sulfation
    CN104447979B|2017-09-26|A kind of method for preparing Nesiritide
    KR840000054B1|1984-01-31|Process for the preparation of thymosin
    同族专利:
    公开号 | 公开日
    DD128973A1|1977-12-21|
    DD128973B1|1979-11-28|
    DE2751026A1|1978-06-01|
    JPS5394541A|1978-08-18|
    GB1584669A|1981-02-18|
    FR2372146A1|1978-06-23|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3705140A|1967-10-05|1972-12-05|Luigi Bernardi|Peptides related to the c-terminal sequence of cck-pz and caerulein|
    US3579494A|1968-07-18|1971-05-18|Squibb & Sons Inc|C-sulfonated tyrosyl peptides related to cholecystokinin-pan-creozymin |
    BR6915336D0|1969-05-27|1973-03-13|Squibb & Sons Inc|REPTIDES CONTAINING TYROSINE-O-SULFATE|
    US3734946A|1969-12-23|1973-05-22|Squibb & Sons Inc|Serine derivatives|
    US3723406A|1969-12-23|1973-03-27|Squibb & Sons Inc|Novel peptides having cholecystokinin activity and intermediates therefor|EP0049500B1|1979-04-30|1984-02-22|Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.|Tyrosine derivatives, process for their production and their use in the synthesis of peptides|
    JPH0235760B2|1982-05-27|1990-08-13|Shionogi & Co|SERUREINNOSHINKISEIZOHO|
    DK489683A|1982-10-27|1984-04-28|Amano Pharma Co Ltd|PROCEDURE FOR PREPARING PEPTIDES|
    US4530836A|1983-05-31|1985-07-23|Amano Pharmaceutical Co., Ltd.|Peptide|
    EP0161468A3|1984-05-07|1988-10-26|Pennwalt Corporation|Process for the solid phase synthesis of peptides which contain sulfated tyrosine|
    NZ218607A|1985-12-19|1989-10-27|Pennwalt Corp|Tri-to acta-peptides with sulphate ester groups: obesity treatment|
    US5086042A|1985-12-19|1992-02-04|Fisons Corporation|Peptides with sulfate ester groups|
    IL84478D0|1986-11-18|1988-04-29|Pennwalt Corp|Peptides with sulfate ester groups and their preparation|
    DK0495013T3|1989-11-27|1995-07-24|Astra Ab|Hexapeptides with sulfate ester groups|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DD19601776A|DD128973B1|1976-11-29|1976-11-29|METHOD FOR THE PRODUCTION OF PEPTIDES CONTAINING TYROSINE SULFATE|
    [返回顶部]